Lietuvos laboratorinės medicinos draugija - financials and debts
Company age: 30 y. 5 mo.
Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | 102,830 | 116,132 | 111,975 | 85,490 |
| Profit before tax | - | - | - | - | -5,593 | 11,394 | 53,058 | 9,072 |
| Net profit | - | - | - | - | -5,593 | 11,394 | 53,058 | 9,072 |
| Equity | 0 | 24,896 | 39,485 | 49,767 | 44,174 | 55,568 | 108,626 | 117,698 |
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 70,431 | 79,900 | 94,489 | 104,771 | 99,178 | 110,572 | 163,630 | 172,702 |
| Total assets | 70,431 | 79,900 | 94,489 | 104,771 | 99,178 | 110,572 | 163,630 | 172,702 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | +12.9% | -3.6% | -23.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | -5.6% | 10.3% | 32.4% | 5.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | -12.7% | 20.5% | 48.8% | 7.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | -5.4% | 9.8% | 47.4% | 10.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -5.4% | 9.8% | 47.4% | 10.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-10-28 | 2023-02-28 | 11.02 |
| 2022-07-25 | 2022-10-27 | 5.41 |
VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lietuvos laboratorines medicinos draugija (code 290738250) is an Association engaged in activities of professional membership organisations. In 2025, it generated revenue of EUR 85.5K and net profit of EUR 9.1K, resulting in a profit margin of 10.6%. Revenue declined from EUR 112.0K in 2024 and EUR 116.1K in 2023, showing a two-year downward trend. Profitability was uneven: net profit increased sharply to EUR 53.1K in 2024 before returning to a more moderate level in 2025. The latest balance sheet shows total assets of EUR 172.7K and equity of EUR 117.7K, indicating a solid capital base. Key ratios for 2025 were ROE at 7.7%, ROA at 5.2%, equity ratio at 68.2%, and asset turnover at 0.50x. The combination of moderate revenue, positive earnings, and a high equity ratio suggests a financially stable organisation with limited asset intensity. No staff data is provided, so revenue per employee cannot be assessed.